Iler, R.K., 1979. Chemistry of <strong>silica</strong> - solubility, polymerization, colloid <strong>and</strong> surface properties <strong>and</strong> biochemistry. John Wiley & Sons, New York, USA. Izquierdo-Barba, I., Martinez, Á., Doadrio, A.L., Pérez-Pariente, J., Vallet-Regí, M., 2005. Release evaluation of drugs from ordered three-dimensional <strong>silica</strong> structures. Eur. J. Pharm. Sci. 26, 365-373. Jakubowicz, J., Smardz, K., Smardz, L., 2007. Characterization of porous <strong>silicon</strong> prepared by powder technology. Physica E Low Dimens. Syst. Nanostruct. 38, 139-143. Jannin, V., Musakhanian, J., Marchaud, D., 2008. Approaches for the development of solid <strong>and</strong> semi-solid lipid-<strong>based</strong> formulations. Adv. Drug Delivery Rev. 60, 734-746. Janssens, S., Van den Mooter, G., 2009. Review: Physical chemistry of solid dispersions. J. Pharm. Pharmacol. 61, 1571-1586. Jugdaohsingh, R., Anderson, S.H., Tucker, K.L., Elliott, H., Kiel, D.P., Thompson, R.P., Powell, J.J., 2002. Dietary <strong>silicon</strong> intake <strong>and</strong> absorption. Am. J. Clin. Nutr. 75, 887 -893. Jugdaohsingh, R., Tucker, K.L., Qiao, N., Cupples, L.A., Kiel, D.P., Powell, J.J., 2003. Dietary <strong>silicon</strong> intake is positively associated with bone mineral density in men <strong>and</strong> premenopausal women of the Framingham Offspring cohort. J. Bone Miner. Res. 19, 297-307. Kansy, M., Senner, F., Gubernator, K., 1998. Physicochemical high throughput screening: Parallel arti<strong>fi</strong>cial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. 41, 1007-1010. Karanth, H., Shenoy, V.S., Murthy, R.R., 2006. Industrially feasible alternative approaches in the manufacture of solid dispersions: A technical report. AAPS PharmSciTech 7, E31-E38. Kawakami, K., 2009. Current status of amorphous formulation <strong>and</strong> other special dosage forms as formulations for early clinical phases. J. Pharm. Sci. 98, 2875-2885. Kenawy, E.-R., Bowlin, G.L., Mans<strong>fi</strong>eld, K., Layman, J., Simpson, D.G., S<strong>and</strong>ers, E.H., Wnek, G.E., 2002. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), <strong>and</strong> a blend. J. Controlled Release 81, 57-64. Kerns, E.H., Di, L., 2003. Pharmaceutical pro<strong>fi</strong>ling in drug discovery. Drug Discov. Today 8, 316- 323. Kilpeläinen, M., Mönkäre, J., Vlasova, M.A., Riikonen, J., Lehto, V.-P., Salonen, J., Järvinen, K., Herzig, K.-H., 2011. Nanostructured porous <strong>silicon</strong> microparticles enable sustained peptide (Melanotan II) delivery. Eur. J. Pharm. Biopharm. 77, 20-25. Kilpeläinen, M., Riikonen, J., Vlasova, M.A., Huotari, A., Lehto, V.P., Salonen, J., Herzig, K.H., Järvinen, K., 2009. In vivo delivery of a peptide, ghrelin antagonist, with mesoporous <strong>silicon</strong> microparticles. J. Controlled Release 137, 166-170. Kim, H.-J., Matsuda, H., Zhou, H., Honma, I., 2006. Ultrasound-triggered smart drug release from a poly(dimethylsiloxane)–mesoporous <strong>silica</strong> composite. Adv. Mater. 18, 3083-3088. Kim, J., Kim, H.S., Lee, N., Kim, T., Kim, H., Yu, T., Song, I.C., Moon, W.K., Hyeon, T., 2008. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core <strong>and</strong> a 52
mesoporous <strong>silica</strong> shell for magnetic resonance <strong>and</strong> fluorescence imaging <strong>and</strong> for drug delivery. Angew. Chem. 120, 8566-8569. Kinnari, P., Mäkilä, E., Heikkilä, T., Salonen, J., Hirvonen, J., Santos, H.A., 2011. Comparison of mesoporous <strong>silicon</strong> <strong>and</strong> non-ordered mesoporous <strong>silica</strong> <strong>materials</strong> as drug carriers for itraconazole. Int. J. Pharm. n/a, n/a. doi:10.1016/j.ijpharm.2011.05.021. Kortesuo, P., Ahola, M., Karlsson, S., Kangasniemi, I., Yli-Urpo, A., Kiesvaara, J., 2000. Silica xerogel as an implantable carrier for controlled drug delivery - evaluation of drug distribution <strong>and</strong> tissue effects after implantation. Bio<strong>materials</strong> 21, 193-198. Kosuge, K., Sato, T., Kikukawa, N., Takemori, M., 2004. Morphological control of rod- <strong>and</strong> <strong>fi</strong>berlike SBA-15 type mesoporous <strong>silica</strong> using water-soluble sodium <strong>silica</strong>te. Chem. Mater. 16, 899-905. Kozlova, S.A., Kirik, S.D., 2010. Post-synthetic activation of silanol covering in the mesostructured <strong>silica</strong>te <strong>materials</strong> MSM-41 <strong>and</strong> SBA-15. Microporous <strong>Mesoporous</strong> Mater. 133, 124-133. Kresge, C.T., Leonowicz, M.E., Roth, W.J., Vartuli, J.C., Beck, J.S., 1992. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359, 710-712. Lai, C.-Y., Trewyn, B.G., Jeftinija, D.M., Jeftinija, K., Xu, S., Jeftinija, S., Lin, V.S.-Y., 2003. A mesoporous <strong>silica</strong> nanosphere-<strong>based</strong> carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters <strong>and</strong> drug molecules. J. Am. Chem. Soc. 125, 4451-4459. Lakshman, J.P., Cao, Y., Kowalski, J., Serajuddin, A.T.M., 2008. Application of melt extrusion in the development of a physically <strong>and</strong> chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol. Pharmaceutics 5, 994-1002. Laza-Knoerr, A.L., Gref, R., Couvreur, P., 2010. Cyclodextrins for drug delivery. J. Drug Targeting 18, 645-656. Lee, C.-H., Cheng, S.-H., Wang, Y.-J., Chen, Y.-C., Chen, N.-T., Souris, J., Chen, C.-T., Mou, C.- Y., Yang, C.-S., Lo, L.-W., 2009. Near-infrared mesoporous <strong>silica</strong> nanoparticles for optical imaging: Characterization <strong>and</strong> in vivo biodistribution. Adv. Funct. Mater. 19, 215-222. Lee, C.-H., Lo, L.-W., Mou, C.-Y., Yang, C.-S., 2008. Synthesis <strong>and</strong> characterization of positivecharge functionalized mesoporous <strong>silica</strong> nanoparticles for oral drug delivery of an antiinflammatory drug. Adv. Funct. Mater. 18, 3283-3292. Lehmann, V., Grüning, U., 1997. The limits of macropore array fabrication. Thin Solid Films 297, 13-17. Lehmann, V., Stengl, R., Luigart, A., 2000. On the morphology <strong>and</strong> the electrochemical formation mechanism of mesoporous <strong>silicon</strong>. Mater. Sci. Eng., B 69-70, 11-22. Lennernäs, H., Abrahamsson, B., 2005. The use of biopharmaceutic classi<strong>fi</strong>cation of drugs in drug discovery <strong>and</strong> development: Current status <strong>and</strong> future extension. J. Pharm. Pharmacol. 57, 273- 285. 53
- Page 1 and 2:
Division of Pharmaceutical Technolo
- Page 3 and 4:
Abstract New chemical entities with
- Page 5 and 6:
Contents Abstract i Acknowledgement
- Page 7 and 8:
List of original publications This
- Page 9:
PAMPA parallel artificial membrane
- Page 12 and 13: lipophilic drugs. The drug molecule
- Page 14 and 15: 2 Review of the literature 2.1 Proc
- Page 16 and 17: the crystalline API into amorphous
- Page 18 and 19: Other solvent methods Spray-freeze-
- Page 20 and 21: particles grow and finally start to
- Page 22 and 23: 2.2.2.2 Surface chemistry Surface i
- Page 24 and 25: Cancer (IARC) has classified inhale
- Page 26 and 27: investigation. The cytotoxicity of
- Page 28 and 29: The shape and surface properties of
- Page 30 and 31: egard to the material toxicity. The
- Page 32 and 33: entrapment of the molecules inside
- Page 34 and 35: thus leaving the pores open for the
- Page 36 and 37: ongoing and it is anticipated that
- Page 38 and 39: 4 Experimental Detailed description
- Page 40 and 41: 4.1.3 Cell culture (IV) Human colon
- Page 42 and 43: espective original publications (I-
- Page 44 and 45: Monolayer integrity was controlled
- Page 46 and 47: groups/nm 2 , OH, is generally high
- Page 48 and 49: However, the HPLC drug loading degr
- Page 50 and 51: Figure 7. Release profiles of ibupr
- Page 52 and 53: evaluated at pH 1.2 in publication
- Page 54 and 55: 6 Conclusions In this study several
- Page 56 and 57: Bahl, D., Bogner, R.H., 2006. Amorp
- Page 58 and 59: Chang, J.-S., Chang, K.L.B., Hwang,
- Page 60 and 61: Gomez-Orellana, I., 2005. Strategie
- Page 64 and 65: Leuner, C., Dressman, J., 2000. Imp
- Page 66 and 67: Passerini, N., Albertini, B., Gonz
- Page 68 and 69: Salonen, J., Lehto, V.-P., 2008. Fa
- Page 70 and 71: Takeuchi, H., Nagira, S., Yamamoto,
- Page 72 and 73: Vishweshwar, P., McMahon, J.A., Bis